Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • NCD 2025
NET Nurse
Donate

Home » News » Closing the NET on Rare Cancers Article published by Melbourne Uni

Closing the NET on Rare Cancers Article published by Melbourne Uni

  • July 11, 2023

Dr Emma Boehm and Associate Professor Richard Tothill from the University of Melbourne, along with Associate Professor Grace Kong and Professor Michael Michael from Peter MacCallum Cancer Centre have released this great article on NETs for the Melbourne University’s online research platform, Pursuit. 

Closing the NET on Rare Cancers explains how patients with neuroendocrine tumours (NETs) can now access cutting-edge treatments and research technology thanks to a new partnership between doctors and scientists.

There is hope that the new approach to research and treatment will help bridge the gap between the clinic and the lab, developing better diagnostic tests and future treatment options for people with NETs.

Read the full article featured in Pursuit HERE.

(L-R), Richard Tothill and Emma Boehm (RADIO Lab); Grace Kong and Michael Michael (Peter Mac ENETs Unit). Picture: University of Melbourne

Share this post

Recent posts

Rare Cancers Roundtable

September 26, 2025

Shining a Light for World Neuroendocrine Cancer Day – Help Us Light Up Australia

September 26, 2025

Celebrating Shane Kent’s Arch2Arc Journey and Fundraising

September 20, 2025

Will Norman Nurse Webinar on Neuroendocrine Cancer

September 19, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousEquitable access for all NET patients
NextDemystifying Neuroendocrine Cancer for patients and nursesNext

Related Posts

Rare Cancers Roundtable

NECA recently attended a Rare Cancers Roundtable to discuss “The value of cancer clinical trials and setting up for success.” Attendees were diverse, including industry,

Shining a Light for World Neuroendocrine Cancer Day – Help Us Light Up Australia

Each year on 10 November for World Neuroendocrine Cancer Day, NeuroEndocrine Cancer Australia joins the global movement to raise awareness of Neuroendocrine Tumours (NETs). This

Will Norman Nurse Webinar on Neuroendocrine Cancer

On 17 September, NeuroEndocrine Cancer Australia, NeuroEndocrine UK, and NeuroEndocrine New Zealand came together to deliver the Will Norman Nurse Webinar on Neuroendocrine Cancer. Hosted

13th INCA Global NET Patient Advocate Summit

This week our CEO Meredith Cummins, in her role as President Elect of the INCA Board of Directors and Chair of the Research Committee, presented at

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin